Sinopharm ’s Covid 19 vaccine trials can resume in Peru , the country 's Health Minister Pilar Mazzetti announced Wednesday . 
On Saturday , Peru ’s clinical trials of the Sinopharm vaccine were temporarily suspended by the Peruvian National Institute of Health after a 64 year old patient , with a history of diabetes , reported a decrease in muscle strength in his legs . 
German Malaga , the head of clinical trials at Sinopharm laboratories in Peru , said at the time that the reason for the symptoms had not yet been determined . 
Mazzetti gave no further details on Wednesday as to whether or not the patient ’s symptoms were linked to the vaccine candidate . 
